![](https://webarchive.library.unt.edu/eot2008/20080923033226im_/http://www.cdc.gov/mmwr/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20080923033226im_/http://www.cdc.gov/mmwr/images/spacer.gif)
Erratum: Vol. 49, No. RR-13
In the MMWR Recommendations and Reports, "Use of Diphtheria
Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series: Supplemental
Recommendations of the Advisory Committee on Immunization Practices (ACIP)," the table on page
2 is incorrect regarding the pertussis antigens contained in
ACEL-IMUNE.® ACEL-IMUNE contains
inactivated pertussis toxin, 3.2 µg; filamentous hemagglutinin, 34 µg;
pertactin, 1.6 µg; and type 2 fimbriae, 0.8
µg. All amounts are approximate.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
Page converted: 11/30/2000
|
![](https://webarchive.library.unt.edu/eot2008/20080923033226im_/http://www.cdc.gov/mmwr/images/spacer.gif) |